Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 101 - 150 out of 9,430

Document Document Title
WO/2014/073450A1
The present invention addresses the problem of providing a drunkenness-relieving agent which can relieve the severity of a badly or heavily drunk state in heavy alcohol use. The means for solving the problem is the use of an insoluble co...  
WO/2014/074007A1
The invention relates to medicine, and more specifically to pharmaceutical agents which can be used for protecting a skin covering from harmful factors of a chemical and biological nature. What is claimed is a therapeutic dermatologic...  
WO/2014/071892A1
The present invention provides methods of modulating the deacetylase activity of SIRT1 by modifying the binding affinity of lamin Ato SIRT1 via interaction modifying compound. The present invention also provides methods of screening SIRT...  
WO/2014/071389A1
Described herein is the surprising discovery that ketone bodies protect cell and tissues from ionizing radiation. Based on this finding, methods of protecting animal tissue and cells from damage caused by radiation exposure are disclosed...  
WO/2014/070038A1
The invention relates to the pharmaceutical industry and the field of medicine and can be used in the creation and administration of solid dosage forms having neuroprotective, antiamnesic, antioxidant, antihypoxic and anti-ischemic activ...  
WO/2014/069682A1
The present invention relates to a monoclonal antibody for inducing apoptosis by binding to a cancer cell and a medical use thereof, and the antibody according to the present invention exhibits activity for cancer cell line-specific bind...  
WO/2014/065369A1
The purpose of the present invention is to provide a tea leaf extract rich in high-stability anthocyanin and exceptional palatability. Specifically, the present invention provides a tea leaf extract containing, with respect to the dry we...  
WO/2014/065275A1
The purpose of the present invention is to provide a novel therapeutic or prophylactic agent for tumor lysis syndrome. The present invention is a therapeutic or prophylactic agent for tumor lysis syndrome, which comprises a 2-phenylthiaz...  
WO/2014/060586A1
The present invention concerns a new family of 2,3-dihydroquinazolin-4(1H)-one compounds of general formula (I), and the use thereof as inhibitors of the toxic effects of toxins with intracellular activity, such as ricin or Shiga toxin, ...  
WO/2014/061783A1
The present invention provides: a novel human-derived monoclonal antibody which can bind specifically to each of toxins (toxin A and toxin B) produced from Clostridium difficile to exsert an excellent neutralizing activity, and an antige...  
WO/2014/056070A1
The present invention includes methods of preventing or minimizing cancer therapy induced alopecia (hair loss) in a subject, the method including administering to the subject an effective amount of (-)-deprenyl, a related compound, or a ...  
WO/2014/057073A1
A compound which is selected from A, B and C, and salts and solvates thereof, as well as conjugates thereof with cell binding agents.  
WO/2014/057120A1
Conjugates of an antibody that binds to CD25 with PBD dimers.  
WO/2014/057117A1
Conjugates of an antibody that binds to CD19 with PBD dimers.  
WO/2014/057119A1
Conjugates of an antibody that binds to CD25 with PBD dimers.  
WO/2014/054005A3
The invention involves the preparation of cholesterol lecithin nanosomes, without propylene glycol, from the complex formed by quercetin (or another flavonol or flavone or a derivative thereof) and 2-hydroxypropyl-β-cyclodextrin, by mea...  
WO/2014/055629A1
The present disclosure provides compounds of formula (I): compositions comprising these compounds, and methods of using these compounds in a variety of applications, such as treatment or suppression of diseases associated with decreased ...  
WO/2014/047715A1
The use of cholesterol-sequestering agents, such as methyl-beta-cyclodextrin, for the treatment of pulmonary surfactant dysfunction is disclosed. It was discovered that oxidative damage to pulmonary surfactant arises due to the interacti...  
WO/2014/048106A1
An ant watered pill containing traditional Chinese medicines and a preparation method thereof. The ant watered pill containing traditional Chinese medicines is prepared from the following raw materials by weight: 700-800g of polyrhachis ...  
WO/2014/048070A1
The present invention provides a composition for promoting erythropoiesis and uses thereof. The composition comprises two or more flavonoid compounds as active ingredients. The flavonoid compound is represented by formula I. R1 is hydrox...  
WO/2014/048953A1
The invention concerns a kit for preventing or treating oxidative stress in humans or animals by means of therapeutically active hydrogen molecules. The hydrogen molecules are formed by reacting a base metal with aqueous acids or bases a...  
WO/2014/045561A1
The present invention addresses the problems of providing an anticancer drug comprising a carotenoid and of providing a novel carotenoid and an antioxidant comprising the novel carotenoid. The above problems are solved by the discovery t...  
WO/2014/040590A1
The invention relates to the use of a humic acid preparation RB4 or lignocellulose carbon isolate for treating diseases in warm-blooded animals caused by a plant protection agent glyphosate, wherein the plant protection agent glyphosate ...  
WO/2014/039712A1
Patient reported outcome (PRO) instruments are useful for collecting information from celiac disease patients, patients with gluten intolerance or gluten sensitivity, and patients on gluten free diets.  
WO/2014/039917A1
Disclosed herein are compounds and methods of using such compounds for treating or suppressing oxidative stress disorders, including mitochondrial disorders, impaired energy processing disorders, neurodegenerative diseases and diseases o...  
WO/2014/037412A1
The invention relates to compositions and methods for improving memory and related functions as alertness, attention, concentration, learning, and language processing. More particularly, the invention relates to compositions comprising a...  
WO/2014/037927A1
The present application relates to the use of chlorate for treating subjects who have been exposed to radiation. More particularly, the application relates to the use of chlorate for treating subjects with acute radiation syndrome. The a...  
WO/2014/039862A1
Methods of modulating, adjusting, and maintenance of the glutathione redox status of an individual, or cell, tissues, bodily fluids, or body compartments of the individual, are disclosed, as are compositions suitable for such modulating,...  
WO/2014/036821A1
Disclosed are a novel compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as a preparation method and a use thereof. The compound is a ternary conjugate formed by combining a thrombolytic peptide...  
WO/2014/032375A1
Disclosed are a lactobacillus plantarum having function of cadmium expelling and the use thereof. The lactobacillus plantarum CCFM8610 of the present invention has acid resistance and good ability of resisting and adsorbing cadmium ions ...  
WO/2014/024984A1
The purpose of the present invention is to provide a hydrogen mixed gas supply device capable of administering a mixed gas having the hydrogen gas concentration and the oxygen gas concentration thereof each appropriately adjusted in acco...  
WO/2014/020219A1
The present invention relates to a method for obtaining a product of Myrciaria dubia fruit with a ripeness level 20 % - 30 %, removing the seeds from the selected fruits and drying the seedless fruits at a temperature of less than 60 ºC...  
WO/2014/017046A1
The present invention addresses the problem of providing a prophylactic and/or therapeutic agent for radiation damage, which has a novel mechanism of action, can prevent and alleviate a wide variety of conditions of radiation damage for ...  
WO/2014/008648A1
A composition comprising reduced glutathione and acetaminophen and preparation method thereof. The main drug of the composition is 0.1%-99.9% reduced glutathione, 99.9%-1% acetaminophen. The composition can be formulated as tablets, sust...  
WO/2014/010656A1
Provided is a blood alcohol concentration reduction accelerating agent which rapidly improves various unpleasant symptoms caused after alcohol consumption such as bloating, nausea and hangover. The blood alcohol concentration reduction a...  
WO/2014/003808A1
The method of extracting kaempferol-based antioxidants from Solenostemma arghel provides a method of producing medicinal antioxidants for usage as anti-inflammatory and analgesic treatments. The kaempferol-based antioxidants are primaril...  
WO/2013/187391A1
The present invention relates to a combination of a sesamin compound, γ-orizanol and a rice germ oil.  
WO/2013/179308A3
The invention relates to a composition with anti-hyperglycemic, antidiabetic and antioxidant activity obtained from the extract of parts of coconut tree selected from roots, bark, trunk, leaves and coconut shell and husk or combinations ...  
WO/2013/172714A1
We describe a composition comprising a non-digestible oligosaccharide for the treatment, prevention or alleviation of a trichothecene mycotoxin exposure associated condition. The non-digestible oligosaccharide may comprise a galactooligo...  
WO/2013/169740A2
Synthetic triterpenoids and methods of using the same to induce gene expression and differentiation of stem or progenitor cells are provided.  
WO/2013/155720A1
A fatigue relief and health care capsule, the capsule being prepared from ganoderma lucidum extract, pseudostellaria root extract, codonopsis pilosula extract, wolfberry fruit extract, and hericium erinaceus extract.  
WO/2013/155717A1
Provided is a body building capsule, comprising Ganoderma lucidum extract, Radix Panacis Quinquefolii extract, milkvetch root extract, Hericium erinaceus extract and Paecilomyces hepialid mycelium.  
WO/2013/149333A1
The present invention relates to food-grade bacteria and methods for removing toxic compounds, including lead, cadmium, mercury, arsenic and pesticides, from contaminated environments or substances.  
WO/2013/152055A1
Radiation - oxidative exposure treatment compositions comprise a mixture of micronutrient multivitamin and trace elements, a mixture of antioxidants and chemopreventative agents, and optionally a mixture of fatty acids. Micronutrient mul...  
WO/2013/148183A2  
WO/2013/143322A1
The present invention relates to the technical field of medicine, and relates specifically to a method for dissolving a flavonoid compound, a carbon glycoside compound, or a stilbene compound and a method for preparing an injection or a ...  
WO/2013/147439A1
The present invention relates to a systemic immunity or gut immunity adjuvant comprising ethanol-soluble cheonggukjang extracts as active ingredients. The immunity adjuvant comprising ethanol-soluble cheonggukjang extracts according to t...  
WO/2013/141759A3
The invention relates to medicine, specifically to neurology and cardiology, namely to the production of a drug in the form of a biologically active nanopreparation having antihypoxic and antioxidant activity. The use of liposomal con...  
WO/2013/142258A1
The present disclosure is directed to compositions comprising encapsulated particles of diethylenetriaminepentaacetate (DTPA) and a zinc salt such as zinc acetate, and to pharmaceutical compositions comprising such encapsulated compositi...  
WO/2013/137777A1
The invention relates to the field of the pharmaceutical industry and medicine. The problem addressed by the present invention is that of producing an effective pharmaceutical composition having neuroprotector, antiamnesic, antioxidan...  

Matches 101 - 150 out of 9,430